Ningbo Sanxing Medical to repurchase, cancel restricted shares

Ningbo Sanxing Medical Electric (SSE:601567) will repurchase and cancel 41,800 restricted shares by September 12, 2025. This action follows the departure of five incentive participants from the company's fourth and fifth-phase restricted stock incentive plans, who no longer meet the eligibility criteria for their unvested shares.

The company's board of directors, at its twenty-fourth meeting on July 11, 2025, approved the repurchase and cancellation. The total share capital will decrease from 1,405,251,200 shares to 1,405,209,400 shares after the transaction. The Shanghai Jin Tiancheng (Hangzhou) Law Firm confirmed that the necessary internal approvals and procedures are in place, aligning with relevant laws and regulations.